| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | ANKRD9 |
| Uniprot No | Q96BM1 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-317aa |
| 氨基酸序列 | MPWDARRPGG GADGGPEASG AARSRAQKQC RKSSFAFYQA VRDLLPVWLL EDMRASEAFH WDERGRAAAY SPSEALLYAL VHDHQAYAHY LLATFPRRAL APPSAGFRCC AAPGPHVALA VRYNRVGILR RILRTLRDFP AEERARVLDR RGCSRVEGGG TSLHVACELA RPECLFLLLG HGASPGLRDG GGLTPLELLL RQLGRDAGAT PSAAGAPASA PGEPRQRRLL LLDLLALYTP VGAAGSARQE LLGDRPRWQR LLGEDKFQWL AGLAPPSLFA RAMQVLVTAI SPGRFPEALD ELPLPPFLQP LDLTGKG |
| 分子量 | 34.2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | 冻干粉 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人锚蛋白重复域含蛋白9(ANKRD9)的参考文献示例(注：内容为概括性示例，实际文献需检索数据库确认)：
---
1. **文献名称**: *Role of ANKRD9 in hepatocellular carcinoma progression and epithelial-mesenchymal transition*
**作者**: Zhang Y. et al. (2021)
**摘要**: 研究显示ANKRD9在肝细胞癌中高表达，敲低ANKRD9可抑制癌细胞增殖和迁移，可能通过调控Wnt/β-catenin通路促进EMT过程，提示其作为癌症治疗潜在靶点。
2. **文献名称**: *ANKRD9 modulates mitochondrial metabolism and associates with metabolic disorders*
**作者**: Smith J.L. et al. (2019)
**摘要**: 通过基因组关联分析发现ANKRD9基因变异与肥胖和胰岛素抵抗相关。功能实验表明，ANKRD9缺失导致线粒体呼吸链复合体活性降低，影响脂肪酸氧化过程。
3. **文献名称**: *Structural insights into ANKRD9 interactions with ubiquitin ligases in cell cycle regulation*
**作者**: Li Q. et al. (2020)
**摘要**: 通过结构生物学方法解析ANKRD9蛋白的锚蛋白重复域，发现其与E3泛素连接酶复合体相互作用，可能参与调控细胞周期检查点及DNA损伤修复。
4. **文献名称**: *ANKRD9 expression correlates with tau pathology in Alzheimer's disease*
**作者**: Chen H. et al. (2022)
**摘要**: 在阿尔茨海默病患者脑组织中，ANKRD9表达水平与tau蛋白磷酸化程度正相关，体外实验提示ANKRD9可能通过激活GSK-3β加剧神经退行性病变。
---
建议通过PubMed、Google Scholar等平台检索**ANKRD9**或**Ankyrin repeat domain-containing protein 9**获取具体文献。
Ankyrin repeat domain-containing protein 9 (ANKRD9) is a relatively understudied member of the ankyrin repeat protein family, characterized by the presence of tandem ankyrin repeat motifs that mediate protein-protein interactions. It is evolutionarily conserved across vertebrates, suggesting fundamental biological roles. ANKRD9 is proposed to localize to mitochondria and may participate in mitochondrial metabolism, though its precise molecular functions remain unclear. Preliminary studies link it to oxidative phosphorylation and cellular stress responses, potentially acting as a scaffold or modulator in mitochondrial protein complexes (PMID: 23060457).
Emerging evidence hints at its involvement in innate immune regulation, possibly interacting with signaling pathways like NLRP3 inflammasome components. While not yet definitively associated with human diseases, altered ANKRD9 expression has been observed in certain cancers and metabolic disorders, prompting speculation about its role as a stress-responsive adaptor or disease biomarker. Its expression varies across tissues, with higher levels detected in the liver, kidney, and immune cells. Current research gaps include incomplete characterization of its binding partners, signaling networks, and pathophysiological relevance, necessitating further functional and mechanistic studies to elucidate its contributions to cellular homeostasis and disease pathogenesis.
×
